Username Password
S&P 500: 2,070.65
Change: +0.46%

HALOZYME THERAPEUTICS INC. (HALO)

Overview
Price 9.46
Price Change Today +$0.44 (+4.88%)
P&P rating Rating: 2
Open Price $9.19
Previous Close $9.02
Daily Range $9.16 - $10.00
52-Week Range $6.88 - $18.18
Volume 4
chart
Top Buy Analysis
BUY: HALO Rating: 2
Company: HALOZYME THERAPEUTICS INC.
Points: -6.36
Start Price: $9.48
Start Date: 06/09/2014 7:28 PM
NHFDSQD2
NHFDSQD2
P&P Score: 0.68
Recs:
Positive pipeline!

Comments: 0 | Comment

Top Sell Analysis
SELL: HALO Rating: 2
Company: HALOZYME THERAPEUTICS INC.
Points: 0.07
Start Price: $6.71
Start Date: 01/01/2008 12:00 AM
rlenz
rlenz
P&P Score: 53.18
Recs:

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

8 Buy
2 Sell
 
Free Options Trader Guide
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 12/26/12 Pfizer Signs a Couple of Deals - Analyst Blog 0
Zacks_Analysts
0.00 12/26/12 Pfizer Signs a Couple of Deals - Analyst Blog 0
Zacks_Analysts
0.00 11/14/12 ViroPharma Presents Cinryze Data - Analyst Blog 0
Zacks_Analysts
0.00 11/14/12 ViroPharma Presents Cinryze Data - Analyst Blog 0
Zacks_Analysts
0.00 10/29/12 Revenues Fall at ViroPharma - Analyst Blog 0
Zacks_Analysts
0.00 10/29/12 Revenues Fall at ViroPharma - Analyst Blog 0
Zacks_Analysts
0.00 09/25/12 Pertaining to Relief for ViroPharma - Analyst Blog 0
Zacks_Analysts
0.00 09/25/12 Pertaining to Relief for ViroPharma - Analyst Blog 0
Zacks_Analysts
0.00 08/10/12 ViroPharma Misses Zacks Estimates - Analyst Blog 0
Zacks_Analysts
0.00 08/10/12 ViroPharma Misses Zacks Estimates - Analyst Blog 0
Pages: [ 1 ]  2   3   4  >>
Commentary
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $9.48
Points: -6.36
Created: 06/09/2014
Positive pipeline!

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $4.99
Points: -20.65
Created: 10/08/2008

Comments: 0 | Comment

Recs:
 
SELL: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $6.71
Points: +0.07
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
SELL: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $7.03
Points: +6.49
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $4.58
Points: +65.49
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $5.61
Points: +27.57
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $4.27
Points: +80.49
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $9.50
Points: -41.48
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $8.29
Points: -26.94
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HALOZYME THERAPEUTICS INC. (HALO) Rating: 2
Start Price: $10.61
Points: -51.89
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
NHFDSQD2 0.68 BUY Week or Less 06/09/2014 $9.48 $9.46
(+4.88%)
-0.21% +6.14% -6.36 view
OpeningBell 39.57 BUY Three to Six Months 10/08/2008 $4.99 $9.46
(+4.88%)
+89.58% +110.23% -20.65
rlenz 53.18 SELL Six Months to a Year 01/01/2008 $6.71 $9.46
(+4.88%)
+40.98% +41.06% +0.07
attic_bathe SELL Six Months to a Year 01/01/2008 $7.03 $9.46
(+4.88%)
+34.57% +41.06% +6.49
knuckking 44.79 BUY Six Months to a Year 01/01/2008 $4.58 $9.46
(+4.88%)
+106.55% +41.06% +65.49
kysoti10 29.49 BUY Six Months to a Year 01/01/2008 $5.61 $9.46
(+4.88%)
+68.63% +41.06% +27.57
eloy 80.61 BUY Six Months to a Year 01/01/2008 $4.27 $9.46
(+4.88%)
+121.55% +41.06% +80.49
Cath 57.10 BUY Six Months to a Year 01/01/2008 $9.50 $9.46
(+4.88%)
-0.42% +41.06% -41.48
JimmyG BUY Six Months to a Year 01/01/2008 $8.29 $9.46
(+4.88%)
+14.11% +41.06% -26.94
Dannyk92 31.28 BUY Six Months to a Year 01/01/2008 $10.61 $9.46
(+4.88%)
-10.84% +41.06% -51.89
Sponsored Links